Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 4
1984 3
1985 6
1986 2
1987 3
1988 2
1989 4
1990 1
1991 2
1992 3
1994 1
1996 2
1997 4
1998 3
1999 3
2000 2
2002 2
2005 1
2006 1
2007 1
2008 1
2010 2
2012 1
2017 2
2018 2
2019 5
2020 3
2021 1
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance.
Zatreanu D, Robinson HMR, Alkhatib O, Boursier M, Finch H, Geo L, Grande D, Grinkevich V, Heald RA, Langdon S, Majithiya J, McWhirter C, Martin NMB, Moore S, Neves J, Rajendra E, Ranzani M, Schaedler T, Stockley M, Wiggins K, Brough R, Sridhar S, Gulati A, Shao N, Badder LM, Novo D, Knight EG, Marlow R, Haider S, Callen E, Hewitt G, Schimmel J, Prevo R, Alli C, Ferdinand A, Bell C, Blencowe P, Bot C, Calder M, Charles M, Curry J, Ekwuru T, Ewings K, Krajewski W, MacDonald E, McCarron H, Pang L, Pedder C, Rigoreau L, Swarbrick M, Wheatley E, Willis S, Wong AC, Nussenzweig A, Tijsterman M, Tutt A, Boulton SJ, Higgins GS, Pettitt SJ, Smith GCM, Lord CJ. Zatreanu D, et al. Among authors: alli c. Nat Commun. 2021 Jun 17;12(1):3636. doi: 10.1038/s41467-021-23463-8. Nat Commun. 2021. PMID: 34140467 Free PMC article.
Molecular basis of USP7 inhibition by selective small-molecule inhibitors.
Turnbull AP, Ioannidis S, Krajewski WW, Pinto-Fernandez A, Heride C, Martin ACL, Tonkin LM, Townsend EC, Buker SM, Lancia DR, Caravella JA, Toms AV, Charlton TM, Lahdenranta J, Wilker E, Follows BC, Evans NJ, Stead L, Alli C, Zarayskiy VV, Talbot AC, Buckmelter AJ, Wang M, McKinnon CL, Saab F, McGouran JF, Century H, Gersch M, Pittman MS, Marshall CG, Raynham TM, Simcox M, Stewart LMD, McLoughlin SB, Escobedo JA, Bair KW, Dinsmore CJ, Hammonds TR, Kim S, Urbé S, Clague MJ, Kessler BM, Komander D. Turnbull AP, et al. Among authors: alli c. Nature. 2017 Oct 26;550(7677):481-486. doi: 10.1038/nature24451. Epub 2017 Oct 18. Nature. 2017. PMID: 29045389 Free PMC article.
Discovery of a Novel Series of Potent SHP2 Allosteric Inhibitors.
Petrocchi A, Grillo A, Ferrante L, Randazzo P, Prandi A, De Matteo M, Iaccarino C, Bisbocci M, Cellucci A, Alli C, Nibbio M, Pucci V, Amaudrut J, Montalbetti C, Toniatti C, Di Fabio R. Petrocchi A, et al. Among authors: alli c. ACS Med Chem Lett. 2023 Apr 17;14(5):645-651. doi: 10.1021/acsmedchemlett.3c00059. eCollection 2023 May 11. ACS Med Chem Lett. 2023. PMID: 37197453
Gametocyte-specific and all-blood-stage transmission-blocking chemotypes discovered from high throughput screening on Plasmodium falciparum gametocytes.
Paonessa G, Siciliano G, Graziani R, Lalli C, Cecchetti O, Alli C, La Valle R, Petrocchi A, Sferrazza A, Bisbocci M, Falchi M, Toniatti C, Bresciani A, Alano P. Paonessa G, et al. Among authors: alli c. Commun Biol. 2022 Jun 6;5(1):547. doi: 10.1038/s42003-022-03510-w. Commun Biol. 2022. PMID: 35668202 Free PMC article.
Mebendazole Potentiates Radiation Therapy in Triple-Negative Breast Cancer.
Zhang L, Bochkur Dratver M, Yazal T, Dong K, Nguyen A, Yu G, Dao A, Bochkur Dratver M, Duhachek-Muggy S, Bhat K, Alli C, Pajonk F, Vlashi E. Zhang L, et al. Among authors: alli c. Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):195-207. doi: 10.1016/j.ijrobp.2018.08.046. Epub 2018 Sep 7. Int J Radiat Oncol Biol Phys. 2019. PMID: 30196056 Free PMC article.
Discovery of a Novel Series of Imidazopyrazine Derivatives as Potent SHP2 Allosteric Inhibitors.
Torrente E, Fodale V, Ciammaichella A, Ferrigno F, Ontoria JM, Ponzi S, Rossetti I, Sferrazza A, Amaudrut J, Missineo A, Esposito S, Palombo S, Nibbio M, Cerretani M, Bisbocci M, Cellucci A, di Marco A, Alli C, Pucci V, Toniatti C, Petrocchi A. Torrente E, et al. Among authors: alli c. ACS Med Chem Lett. 2023 Jan 10;14(2):156-162. doi: 10.1021/acsmedchemlett.2c00454. eCollection 2023 Feb 9. ACS Med Chem Lett. 2023. PMID: 36793438 Free PMC article.
Serum erythropoietin levels, breast cancer and breast cancer-initiating cells.
Bhat K, Sandler K, Duhachek-Muggy S, Alli C, Cheng F, Moatamed NA, Magyar CE, Du L, Li G, McCloskey S, Vlashi E, Pajonk F. Bhat K, et al. Among authors: alli c. Breast Cancer Res. 2019 Jan 30;21(1):17. doi: 10.1186/s13058-019-1100-9. Breast Cancer Res. 2019. PMID: 30700319 Free PMC article.
Hypertension Optimal Treatment (HOT) trial.
Avanzini F, Marchioli R, Alli C, Tognoni G. Avanzini F, et al. Among authors: alli c. Lancet. 1998 Aug 15;352(9127):571-2; author reply 574-5. doi: 10.1016/S0140-6736(05)79277-1. Lancet. 1998. PMID: 9716079 No abstract available.
68 results